Principal Financial Group’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
GCM
N
Principal Financial Group's FLNA Position: Q2 2024 in Review
Principal Financial Group sold out of Filana Therapeutics (FLNA) in Q2 2024, closing a stake of 10,965 shares — an estimated $222K sold.
Principal Financial Group first reported a position in FLNA in Q2 2014 and held it in 16 quarters. The position peaked at $10.8M in Q2 2021. 145 funds tracked by Wall St. Rank hold FLNA as of Q2 2024.
- Principal Financial Group reported no remaining Filana Therapeutics position as of Q2 2024 after selling out during the quarter.
- Principal Financial Group sold 10,965 Filana Therapeutics shares in Q2 2024, an estimated $222K.
- Principal Financial Group first reported a position in Filana Therapeutics in Q2 2014 and held it in 16 quarters.
- Principal Financial Group's Filana Therapeutics position peaked at $10.8M in Q2 2021.
- 145 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2024.
Based on Principal Financial Group's 13F filing for Q2 2024, filed 29 Jul 2024.